<i>Limosilactobacillus reuteri</i> M4-100 Mitigates the Pathogenicity of <i>Escherichia coli</i> Strain HMLN-1 in an Intestinal Epithelial Model and Modulates Host Cell Gene Expression.

Microorganisms · 2025 · PMC12195564 · PMID 40572318

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

A highly significant reduction ( p < 0.0001) was also found in the invasion of the co-culture by the HMLN-1 strain when it was co-inoculated (65.6%) and pre-inoculated (97%) with L. reuteri M4-100 ( Figure 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;Limosilactobacillus reuteri&lt;/i&gt; M4-100 Mitigates the Pathogenicity of &lt;i&gt;Escherichia coli&lt;/i&gt; Strain HMLN-1 in an Intestinal Epithelial Model and Modulates Host Cell Gene Expression.

The sentences

<i>Limosilactobacillus reuteri</i> M4-100 Mitigates the Pathogenicity of <i>Escherichia coli</i> Strain HMLN-1 in an Intestinal Epithelial Model and Modulates Host Cell Gene Expression.